COM:CUREVAC
CureVac
- Stock
Last Close
2.56
22/11 21:00
Market Cap
697.59M
Beta: -
Volume Today
473.83K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
---|---|---|---|---|---|---|---|
net income | -71.13M - | -100.13M 40.76% | -129.85M 29.69% | -412.50M 217.68% | -249.16M 39.60% | -254.83M 2.28% | |
depreciation and amortization | 3.78M - | 7.16M 89.47% | 10.67M 48.95% | 15.67M 46.88% | 23.74M 51.47% | 26.67M 12.34% | |
deferred income tax | 52K - | -847K 1,728.85% | -2.87M 238.37% | 199.02M 7,044.28% | -1.58M 100.80% | -112.64K 92.88% | |
stock based compensation | -4.25M - | 19.56M 560.55% | 14.24M 27.21% | 14.96M 5.03% | 9.19M 38.59% | 7.70M 16.20% | |
change in working capital | -1.08M - | -22.65M 1,987.65% | 578.57M 2,654.30% | -69.55M 112.02% | -125.56M 80.54% | -66.78M 46.82% | |
accounts receivables | -5.59M - | -10.12M 80.82% | -32.30M 219.27% | -19.82M 38.64% | -16.68M 15.83% | -7.92M 52.55% | |
inventory | 878K - | -3.25M 469.70% | -8.33M 156.75% | -227.46M 2,629.30% | -47.85M 78.96% | -46.96M 1.87% | |
accounts payables | 9.40M - | -9.58M 201.94% | 620.30M 6,572.30% | 179.32M 71.09% | -96.19M 153.64% | -29.37M 69.47% | |
other working capital | -5.77M - | 296K 105.13% | -1.10M 470.27% | -1.58M 44.43% | 35.16M 2,320.85% | 17.47M 50.32% | |
other non cash items | -1.48M - | 9.93M 771.53% | 51.63M 419.86% | -480.74M 1,031.08% | 57.20M 111.90% | 170.24M 197.64% | |
net cash provided by operating activities | -74.11M - | -86.96M 17.34% | 522.40M 700.72% | -733.13M 240.34% | -286.18M 60.96% | -262.40M 8.31% | |
investments in property plant and equipment | -14.72M - | -12.22M 16.97% | -47.35M 287.37% | -127.90M 170.11% | -93.22M 27.11% | -54.07M 42.00% | |
acquisitions net | -277K - | ||||||
purchases of investments | -1.16M - | ||||||
sales maturities of investments | 10.46M - | 38.08M 264.09% | |||||
other investing activites | 2.33M - | 3.24M 39.31% | -2.88M - | ||||
net cash used for investing activites | -4.26M - | 28.18M 760.91% | -45.27M 260.65% | -127.90M 182.50% | -93.50M 26.90% | -54.07M 42.17% | |
debt repayment | -112K - | -1.91M 1,605.36% | -97.74M 5,017.49% | -28.18M 71.17% | -4.22M 85.02% | -5.19M 23.03% | |
common stock issued | 867.72M - | 404.06M 53.43% | 66.48M 83.55% | 231.25M 247.82% | |||
common stock repurchased | -34.10M - | ||||||
dividends paid | |||||||
other financing activites | 69.89M - | 49.86M 28.66% | 3.19M 93.61% | 910K 71.44% | 236.09M 25,843.52% | ||
net cash used provided by financing activities | -112K - | 67.98M 60,795.54% | 819.83M 1,106.01% | 344.96M 57.92% | 63.17M 81.69% | 226.16M 258.00% | |
effect of forex changes on cash | 213K - | 107K 49.77% | -5.05M 4,822.43% | 4.94M 197.68% | 836K 83.06% | -1.15M 237.68% | |
net change in cash | -78.27M - | 9.30M 111.89% | 1.29B 13,785.52% | -511.13M 139.56% | -315.67M 38.24% | -91.62M 70.97% | |
cash at beginning of period | 99.65M - | 21.38M 78.55% | 30.68M 43.52% | 1.32B 4,210.37% | 811.46M 38.65% | 494.41M 39.07% | |
cash at end of period | 21.38M - | 30.68M 43.52% | 1.32B 4,210.37% | 811.46M 38.65% | 495.80M 38.90% | 402.78M 18.76% | |
operating cash flow | -74.11M - | -86.96M 17.34% | 522.40M 700.72% | -733.13M 240.34% | -286.18M 60.96% | -262.40M 8.31% | |
capital expenditure | -14.72M - | -12.22M 16.97% | -47.35M 287.37% | -127.90M 170.11% | -93.22M 27.11% | -54.07M 42.00% | |
free cash flow | -88.83M - | -99.19M 11.66% | 475.05M 578.94% | -861.03M 281.25% | -379.40M 55.94% | -316.46M 16.59% |
All numbers in (except ratios and percentages)